| Financial Year |
March 31 2023 |
| Monetary Funds |
3,144,554,895.94 |
| Held-for-trading Financial Assets |
1,583,435,270.29 |
| Notes Receivable |
27,972,129.32 |
| Accounts Receivable |
3,048,604,101.99 |
| Advances to Suppliers |
87,145,562.48 |
| Other Receivables |
292,121,591.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,432,251,567.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,360,640.55 |
| Other Current Assets |
76,744,376.30 |
| Total Current Assets |
9,716,464,618.46 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
39,599,159.08 |
| Investment Properties |
-- |
| Fixed Assetes |
1,712,519,790.48 |
| Under-construction Projects |
69,103,421.79 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
409,431,343.94 |
| R&D expenses |
-- |
| Goodwill |
63,529,740.20 |
| Long-Term Deferred and Prepaid Expenses |
114,305,830.88 |
| Deferred Income Tax Assets |
204,883,254.50 |
| Other Non-Current Assets |
4,106,200.89 |
| Sub-Total of Non-Current Assets |
2,960,432,888.94 |
| Total Assets |
12,676,897,507.40 |
| Short-Term Loans |
205,236,556.66 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
3,422,983,367.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
119,178,489.77 |
| Taxes Payable |
189,492,768.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
418,170,417.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
190,535,539.51 |
| Other Current Liabilities |
83,836,562.30 |
| Sub-Total of Current Liabilities |
4,720,516,045.11 |
| Long-term Loans |
16,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
14,922,058.45 |
| Deferred Income Tax Liabilities |
149,929,197.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
378,766,427.30 |
| Total Liabilities |
5,099,282,472.41 |
| Paid-In Capital(Or Share Stock) |
926,933,050.00 |
| Capital Surplus |
433,166,932.89 |
| Surplus Reserve |
464,201,654.91 |
| LESS:Treasury Stock |
227,567,430.70 |
| Undistributed Profits |
5,555,985,793.09 |
| Minority Stockholder's Interest |
434,199,633.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,143,415,401.26 |
| Owner's Equity（Stockholder's Equity） |
7,577,615,034.99 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,676,897,507.40 |
